tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeff Jones, 156 are a BUY (96.89%), 5 are a HOLD (3.11%).
Analyst Jeff Jones, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 36.72% that have a potential upside of 78.61% achieved within 148 days.
Jeff Jones’s has documented 303 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALMS, Alumis at 02-Sep-2026.
Analyst best performing recommendations are on FUSN (FUSION PHARMACEUTICALS).
The best stock recommendation documented was for CLRB (CELLECTAR BIOSCIENCES) at 11/19/2024. The price target of $12 was fulfilled within 22 days with a profit of $36.3 (75.16%) receiving and performance score of 34.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jul-2024
$34
1 months 28 days ago
(03-Sep-2026)
0/4 (0%)
$11.13 (48.67%)
Buy Since 23-Jul-2024
$29
$22.27 (330.91%)
$39
1 months 29 days ago
(02-Sep-2026)
0/6 (0%)
$18.65 (180.19%)
Buy Since 25-Jul-2025
$25
$18.27 (271.47%)
$51
1 months 29 days ago
(02-Sep-2026)
1/5 (20%)
$14.65 (141.55%)
166
Buy Since 30-Jan-2025
$37
$30.27 (449.78%)
$55
1 months 29 days ago
(02-Sep-2026)
1/5 (20%)
$26.65 (257.49%)
250
Hold Since 03-Aug-2026
$15
$8.27 (122.88%)
$25
1 months 29 days ago
(02-Sep-2026)
19/20 (95%)
$4.65 (44.93%)
226
Which stock is Jeff Jones most bullish on?
Which stock is Jeff Jones most reserved on?
What Year was the first public recommendation made by Jeff Jones?
